Home > Income Statement > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
Revenue

    Back to Income Statement
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
Best 1M Momentum Large Cap Stocks
COMMUNITY POLL
for TORRENT PHARMACEUTICALS
Please provide your vote to see the results

TORRENT PHARMACEUTICALS Last 5 Year Revenue History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Net Sales ₹9,620 Cr₹8,508 Cr₹8,005 Cr₹7,939 Cr₹7,673 Cr

What is the latest Revenue of TORRENT PHARMACEUTICALS ?

The latest Revenue ratio of TORRENT PHARMACEUTICALS is ₹9,620 Cr based on Mar2024 Consolidated results.
Year Revenue
Mar2024₹9,620 Cr
Mar2023₹8,508 Cr
Mar2022₹8,005 Cr
Mar2021₹7,939 Cr
Mar2020₹7,673 Cr

How is Revenue of TORRENT PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2024 ₹9,620 Cr
13.07
Mar2023 ₹8,508 Cr
6.29
Mar2022 ₹8,005 Cr
0.82
Mar2021 ₹7,939 Cr
3.47
Mar2020 ₹7,673 Cr -

Compare Revenue of peers of TORRENT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS ₹109,458.9 Cr -0.8% 6.8% 25.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹416,393.0 Cr -2.8% 7.6% 8.4% Stock Analytics
DIVIS LABORATORIES ₹153,258.0 Cr -2.3% 0.8% 72.7% Stock Analytics
CIPLA ₹116,434.0 Cr -5.4% -1.5% 0.8% Stock Analytics
MANKIND PHARMA ₹99,974.0 Cr 2.1% 3.7% 9.5% Stock Analytics
DR REDDYS LABORATORIES ₹95,465.9 Cr -5.5% 1.6% -5.1% Stock Analytics


TORRENT PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS

-0.8%

6.8%

25.6%

SENSEX

0.7%

4%

6.3%


You may also like the below Video Courses